Nature Communications (Jul 2023)

Supersulphides provide airway protection in viral and chronic lung diseases

  • Tetsuro Matsunaga,
  • Hirohito Sano,
  • Katsuya Takita,
  • Masanobu Morita,
  • Shun Yamanaka,
  • Tomohiro Ichikawa,
  • Tadahisa Numakura,
  • Tomoaki Ida,
  • Minkyung Jung,
  • Seiryo Ogata,
  • Sunghyeon Yoon,
  • Naoya Fujino,
  • Yorihiko Kyogoku,
  • Yusaku Sasaki,
  • Akira Koarai,
  • Tsutomu Tamada,
  • Atsuhiko Toyama,
  • Takakazu Nakabayashi,
  • Lisa Kageyama,
  • Shigeru Kyuwa,
  • Kenji Inaba,
  • Satoshi Watanabe,
  • Péter Nagy,
  • Tomohiro Sawa,
  • Hiroyuki Oshiumi,
  • Masakazu Ichinose,
  • Mitsuhiro Yamada,
  • Hisatoshi Sugiura,
  • Fan-Yan Wei,
  • Hozumi Motohashi,
  • Takaaki Akaike

DOI
https://doi.org/10.1038/s41467-023-40182-4
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 25

Abstract

Read online

Abstract Supersulphides are inorganic and organic sulphides with sulphur catenation with diverse physiological functions. Their synthesis is mainly mediated by mitochondrial cysteinyl-tRNA synthetase (CARS2) that functions as a principal cysteine persulphide synthase (CPERS). Here, we identify protective functions of supersulphides in viral airway infections (influenza and COVID-19), in aged lungs and in chronic lung diseases, including chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF). We develop a method for breath supersulphur-omics and demonstrate that levels of exhaled supersulphides increase in people with COVID-19 infection and in a hamster model of SARS-CoV-2 infection. Lung damage and subsequent lethality that result from oxidative stress and inflammation in mouse models of COPD, IPF, and ageing were mitigated by endogenous supersulphides production by CARS2/CPERS or exogenous administration of the supersulphide donor glutathione trisulphide. We revealed a protective role of supersulphides in airways with various viral or chronic insults and demonstrated the potential of targeting supersulphides in lung disease.